Please sign in to follow a disease.
Probi AB
Clinical trials sponsored by Probi AB, explained in plain language.
Now part of
Symrise AG
SY1
XETRA
Probiotics company developing and selling probiotic strains.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.